PREVALENCE OF VULVOVAGINAL CANDIDIASIS IN SEXUALLY ACTIVE FEMALES WITH ANTIFUNGAL SUSCEPTIBILITY PATTERNS OF THE ISOLATES by Sahoo, Subhalaxmi et al.
 38 
 
PREVALENCE OF VULVOVAGINAL CANDIDIASIS IN SEXUALLY ACTIVE FEMALES 
WITH ANTIFUNGAL SUSCEPTIBILITY PATTERNS OF THE ISOLATES  
Subhalaxmi Sahoo1, Indrani Mohanty2, Banojini Parida3, Satyadarsi Patnaik4  
1PG student, 2Assistant Professor, 3Professor & Head of Department, 4Professor, Department of Microbiology MKCG 
Medical College, Orissa, India  
Original Article 
International Journal of Clinical and Biomedical Research. © 2018  Sumathi Publications.  
This is an Open Access article which permits unrestricted non-commercial use, provided the original work is properly cited.  
INTRODUCTION 
Vulvovaginal candidiasis  is the most common fungal 
infection affecting 75% of sexually active women and 
causing significant morbidity, healthcare cost, sexual 
dysfunction, discomfort and pain *1,2+. VVC is caused 
by Candida, a saprophytic yeast causing opportunistic 
infection in conditions when there is decrease in vagi-
nal pH or conditions predisposing to alteration of local 
defence mechanisms like pregnancy, diabetes mellitus, 
malnutrition, contraceptives, tight fitting and synthetic 
inner wears, poor  menstrual hygiene and patients on 
immunosuppressive drugs *3+. VVC if not treated may 
lead to infertility due to pelvic inflammatory disease in 
young women and chorioamnionitis followed by abor-
tion andprematurity in pregnant women *4+.  Candidial 
vulvovaginitis is mainly due to C. albicans but more 
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recently non-albicans Candida species are increasingly 
being reported as well as yeasts belonging to other 
genera.  There have been reports of variable resistance 
to antifungal agents by non-albicans Candida making 
treatment a serious clinical challenge *5+. To avoid 
spread of resistance of Candida species by injudicious 
use of topical and systemic antifungals, identification of 
the Candida isolates and antifungal susceptibility 
testing of the routine samples is essential. The present 
study was aimed to determine the prevalence, poten-
tial risk factors, predisposing conditions and antifungal 
susceptibility pattern of the Candida isolates in sexually 
active female in this region. 
MATERIALS AND METHODS 
Study design: An observational study  
Ethics approval: Study was approved by Institutional 
Ethics Committee and written informed consent were 
taken from all the patients prior to sample collection. 
Study location: The present study was carried out in 
the department of Microbiology 
Study period: January 2016 to December 2017 
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Sample size: The study group included 240  
Inclusion criteria: Sexually active women between 18 
to 45 years who presented with vaginal discharge and /
or itching/burning, dysuria or low abdominal pain.  
Exclusion criteria: Patient with pregnancy, on antimi-
crobial therapy, menstruating, undergone hysterecto-
my, carcinoma cervix, uterine fibroids and prolapsed 
uterus were excluded from the study.  
Methodology: A detailed history of each patient with 
respect to age, occupation, socioeconomic status, mari-
tal status, personal hygiene, contraceptive practices, 
sexual behaviour, past and present history of sexually 
transmitted infections and high risk behaviour of their 
partners were recorded in form of semi-structured 
questionnaires.  
Two sterile cotton swabs were used to collect samples 
from the lateral wall of the vagina.  Wet mount micros-
copy and gram staining was done from one of the 
swabs and the other swab was used for culture on 
Sabouraud’s Dextrose Agar (Hi-Media, Mumbai, India) 
supplemented with 0.06mg/ml gentamicin. The isolates 
were identified based on morphology, germ tube pro-
duction, chlamydospore formation on cornmeal agar 
(Hi-Media, Mumbai, India), sugar assimilation and fer-
mentation tests and growth on CHROM agar Candida 
(Hi-Media, Mumbai, India). 
Antifungal susceptibility testing was performed by Kirby 
Bauer disc diffusion method using commercially availa-
ble antifungal discs of clotrimazole, fluconazole, itra-
conazole, ketoconazole and amphotericin B on Antimy-
cotic sensitivity test agar M1336-500G(HI-
Media,Mumbai,India). The zones were compared with 
the zone charts of Hi-Media Laboratories to know the 
antimicrobial sensitivity pattern.   
RESULTS 
Most of the patients belonged to the age group of 26 
to 35 years (39.1%) followed by 36 to 45 years (34.6%). 
Majority of the patients were from rural areas (61.7%). 
*Table 1+. VVC was more prevalent among women with 
low education (illiterate-5.4% and up to primary school 
47.1%), daily labourers (38.7%) and oral contraceptive 
pill users (38.3%).*Table 2, 3  and4+. Out of the 240 clin-
ically diagnosed cases of VVC, 87 cases of Candida spe-
cies were isolated. Candida albicans (57.1%) was the 
most common isolate followed by Candida glabrata
(25.3%), Candida tropicalis (7.7%), and Candida para-
silosis (5.5%). From four patients Trichosporon asahii 
(4.4%) were isolated. *Table.5+ Most of the isolates 
were sensitive to clotrimazole (90.1%) followed by flu-
conazole (83.5%). Most of the yeast isolates were re-
sistant to  ketoconazole (31.8%). *Table.6+ 
 
 
Table 1. Demographic details  
 
Table 2. Educational status (n=240) 
 
Table 3. Occupation (n=240) 
 
Table 4. Predisposing factor (n=240) 







15-25 63 (26.3) 18 43 
26-35 94 (39.2) 41 59 
36-45 83 (34.6) 33 46 




Education Cases (%) 
Illiterate 13 (5.4) 
Primary school 113 (47.1) 
High school 65 (27.1) 
Higher secondary school 31 (12.9) 
Degree 18 (7.5) 
Occupation Cases (%) 
Service Holders 21 (8.8) 
Business 13 (5.4) 
Daily wage worker 93 (38.7) 
Housewife 72 (30) 
Student 41 (17.1) 
Yeasts isolated Number % 















Trichosoporon asahii 4 4.4% 
Total 91 100% 
Predisposing factors Cases (%) 
Diabetes 79 (32.9) 
OCP  92 (38.3) 
HIV 32 (13.3) 
Steroid therapy 21 (8.8) 
Malignancy 16 (6.7) 
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VVC is a common infection with 50-72% of all women 
having at least one episode of vaginal candidiasis in 
their life time and 40-50% of them having recurrent 
episodes. In our study the highest frequency of VVC 
was seen in the age group of 26-35 years (39.2%) fol-
lowed by 36-45 years (34.6%).This may be due to maxi-
mum sexual and reproductive activity in these age 
groups.The prevalence of clinically diagnosed cases of 
VVC was more in rural areas (61.7%) compared to ur-
ban areas (38.3%). Similar observation was reported by 
Rati et al with a highest frequency of vaginal candidia-
sis in the age  group of 26-35yrs *6+. Vulvovaginal can-
didiasis was more prevalent among women with low 
education (47.1%), low socioeconomic status (38.7%) 
and those using OCP(38.3%). Non-usage of sanitary 
toilet, use of homemade napkins during menstruation, 
poor personal hygiene, low level of literacy, and poor 
knowledge of reproductive health, limited exposure to 
mass media and inaccessibility to health care services 
were the contributory factors leading to VVC.  High 
estrogen Oral contraceptive pills alters the normal bac-
terial flora, predisposing  to vaginal cololonisation by 
Candida, a similar mechanism seen in pregnancy *7+. In 
this study Candida albicans (57.1%) were isolated fol-
lowed by Candida glabrata (25.3%),Candida tropicalis 
(7.7%),Candida parasilopsis (5.5%).This study is in ac-
cordance to Mahmoudabadi  AZ et al, in which Candida 
albicans was the most common species isolated fol-
lowed by Candida glabrata *2+. Study conducted by 
Jackson et al  in West Indies also had similar findings 
*8+. This study was contrary to a study  conducted by 
Mohanty  et al in which Candida glabrata was the most 
common species among the isolates followed by Can-
dida albicans *9+. Varsha et al in their study showed  an 
increasing prevalence of non  albicans Candida species 
among vulvovaginitis cases  in child bearing age group 
women *10+. In antifungal susceptibility testing, most 
fungal  isolates were sensitive to clotrimazole (90.1%) 
followed by fluconazole (83.5%). A study conducted by 
Jithendra et al found that all fungal isolates were 100% 
sensitive to voriconazole and some degree of re-
sistance to fluconazole *11+. Mahmoudabadi et al in his 
study revealed that none of the Candida isolates tested 
were resistant to clotrimazole, miconazole and nystatin 
whereas, in our study we found Candida albicans was 
resistant to ketoconazole in 12 isolates, amphotericin B 
in 11 isolates and itraconazole in 10 isolates*2+. 
CONCLUSION 
The prevalence of VVC in our study was 36.3%.Though 
in our study C. albicans was the predominate isolate, 
non albicans Candida and Trichosporon asahii were also 
isolated. Resistance to azoles is emerging among yeasts 
which necessitates the isolation, identification and anti-
fungal susceptibility testing in cases of VVC routinely to 
prevent spread of resistance. 
Suggestions: VVC in sexually active females in the re-
productive age group may lead to infertility and other 
complications. Education about sexual health and hy-
giene in young females is necessary as this was the 
most common age group affected. 
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